Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan

• Asıl Yazarlar: Dana Dadanbekova (Yazar), Kairat Zhakipbekov (Yazar), Almat Kodasbayev (Yazar), Ubaidilla Datkhayev (Yazar), Guenka Petrova (Yazar), Konstantin Tachkov (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Pensoft Publishers, 2024-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The aim of this study is to evaluate the cost-effectiveness of 2 different therapies of cardiomyopathy (CM) after COVID -19. The focus of the study is fixed dose combination (FDC) of sacubitril/valsartan and standard therapy in Kazakhstan. This is written from the point of view of the health insuran...